New AI Model Could Cut the Costs of Developing Protein Drugs

New AI model could cut the costs of developing protein drugs

MIT chemical engineers used AI to optimize the selection of codon sequences for protein drugs produced by yeast, which could reduce the costs of developing and manufacturing these drugs.

Innovative AI Model Promises to Slash Costs in Protein Drug Development

In a groundbreaking study coming out of MIT, chemical engineers have revolutionized the way industrial yeast is programmed to manufacture critical proteins, introducing a novel artificial intelligence–driven method that promises to significantly minimize the time and expense involved in biopharmaceutical production. The study leverages the capabilities of large language models (LLMs), commonly used in natural […]